Evelo Biosciences Sees Unusually Large Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading activity on Wednesday. Investors acquired 1,885 put options on the company. This represents an increase of approximately 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

The business has a fifty day simple moving average of $0.03 and a 200-day simple moving average of $0.05. Evelo Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $13.93.

Institutional Investors Weigh In On Evelo Biosciences

An institutional investor recently raised its position in Evelo Biosciences stock. Vanguard Group Inc. grew its position in shares of Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 357,711 shares of the company’s stock after buying an additional 201,815 shares during the quarter. Vanguard Group Inc. owned 1.88% of Evelo Biosciences worth $1,402,000 as of its most recent filing with the Securities & Exchange Commission. 0.31% of the stock is currently owned by institutional investors and hedge funds.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.